Anticoagulation of patients on chronic warfarin undergoing arrhythmia device surgery: Wide variability of perioperative bridging in Canada

Heart Rhythm

Volumn 6, Issue 9, 2009, Pages 1276-1279

  Krahn, Andrew D ^a   Healey, Jeffrey S ^a   Simpson, Christopher S ^b   Essebag, Vidal ^c   Sivakumaran, Soori ^d   Birnie, David H ^e  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^e UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Anticoagulation; Bridging; Heparin; Pacemaker

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN; ANTICOAGULANT AGENT;

AGE DISTRIBUTION; ANTICOAGULANT THERAPY; ARTICLE; ARTIFICIAL HEART PACEMAKER; CANADA; CHRONIC DRUG ADMINISTRATION; CLINICAL PRACTICE; CLINICAL PROTOCOL; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; HEALTH SURVEY; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HUMAN; HYPERTENSION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RISK REDUCTION; STROKE; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; AGED; ATRIAL FIBRILLATION; CHRONIC DISEASE; HEALTH CARE SURVEY; HEART PACING; HEART SURGERY; HEMORRHAGE; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; TIME;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; CANADA; CARDIAC PACING, ARTIFICIAL; CARDIAC SURGICAL PROCEDURES; CHRONIC DISEASE; HEALTH CARE SURVEYS; HEMORRHAGE; HUMANS; PERIOPERATIVE CARE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; THROMBOEMBOLISM; TIME FACTORS;

EID: 68949205676     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2009.05.027     Document Type: Article

References (23)

1. Wiegand U.K., LeJeune D., Boguschewski F., et al. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy. Chest 126 (2004) 1177-1186
2. Giudici M.C., Paul D.L., Bontu P., and Barold S.S. Pacemaker and implantable cardioverter defibrillator implantation without reversal of warfarin therapy. Pacing Clin Electrophysiol 27 (2004) 358-360
3. Douketis J.D., Berger P.B., Dunn A.S., et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133 (2008) 299S-339S
4. Garcia D.A., Regan S., Henault L.E., et al. Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med 168 (2008) 63-69
5. Kearon C., and Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 336 (1997) 1506-1511
6. Dunn A.S., and Turpie A.G. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 163 (2003) 901-908
7. Blacker D.J., Wijdicks E.F., and McClelland R.L. Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy. Neurology 61 (2003) 964-968
8. Torn M., and Rosendaal F.R. Oral anticoagulation in surgical procedures: risks and recommendations. Br J Haematol 123 (2003) 676-682
9. Kovacs M.J., Kearon C., Rodger M., et al. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 110 (2004) 1658-1663
10. Carrel T.P., Klingenmann W., Mohacsi P.J., Berdat P., and Althaus U. Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review. J Heart Valve Dis 8 (1999) 392-398
11. al-Khadra A.S. Implantation of pacemakers and implantable cardioverter defibrillators in orally anticoagulated patients. Pacing Clin Electrophysiol 26 (2003) 511-514
12. Marquie C., De Geeter G., Klug D., et al. Post-operative use of heparin increases morbidity of pacemaker implantation. Europace 8 (2006) 283-287
13. Michaud G.F., Pelosi Jr. F., Noble M.D., Knight B.P., Morady F., and Strickberger S.A. A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation. J Am Coll Cardiol 35 (2000) 1915-1918
14. Goldstein D.J., Losquadro W., and Spotnitz H.M. Outpatient pacemaker procedures in orally anticoagulated patients. Pacing Clin Electrophysiol 21 (1998) 1730-1734
15. Gage B.F., Waterman A.D., Shannon W., Boechler M., Rich M.W., and Radford M.J. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285 (2001) 2864-2870
16. Douketis J.D., Crowther M.A., Cherian S.S., and Kearon C.B. Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery. Chest 116 (1999) 1240-1246
17. Birnie D., Healey J.S., Krahn A., et al. Bridge or continue Coumadin for device surgery: a randomized controlled trial rationale and design. Curr Opin Cardiol 24 (2009) 82-87
18. Reynolds M.R., Cohen D.J., Kugelmass A.D., et al. The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol 47 (2006) 2493-2497
19. Dunn A.S., Spyropoulos A.C., and Turpie A.G. Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT). J Thromb Haemost 5 (2007) 2211-2218
20. O'Donnell M.J., Kearon C., Johnson J., et al. Brief communication: preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin. Ann Intern Med 146 (2007) 184-187
21. Spyropoulos A.C., Bauersachs R.M., Omran H., and Cohen M. Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy. Curr Med Res Opin 22 (2006) 1109-1122
22. Jaffer A.K., Ahmed M., Brotman D.J., et al. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol. J Thromb Thrombolysis 20 (2005) 11-16
23. de Oliveira J.C., Martinelli M., D'Orio Nishioka S.A., et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators. results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol 2 (2009) 29-34